Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Weaning is an important process to gradually separate mechanically ventilated patients from ventilators. A good weaning strategy aims to early identify mechanically ventilated patients who are ready for extubation but not to prematurely extubate them. Spontaneous breathing trial (SBT) is a test to assess the patient's ability to breathe spontaneously when extubated. Several methods have been used to conduct an SBT, including T-piece breathing, low-level pressure support ventilation (PSV) of 5-7 cm H2O, continuous positive airway pressure and automatic tube compensation (ATC).
The investigators hypothesized that an SBT with inspiratory pressure augmentation increases initial SBT success, reduces the length of invasive mechanical ventilation (iMV) support and does not increase reintubation risk as compared with T-piece, which result in a higher proportion of patients successfully liberated from iMV in the inspiratory pressure augmentation group. However, inspiratory pressure augmentation significantly reduces work of breathing on an SBT as compared with T-piece. Patients extubated following an SBT with inspiratory pressure augmentation may experience increased respiratory effort after extubation and this may increase the use of noninvasive ventilation after extubation. An SBT with inspiratory pressure augmentation increases iMV free days but not MV free days as compared with T-piece. Longer iMV free days may be associated with a lower mortality due to fewer iMV related complication.
This study is a pragmatic, cluster-randomized, multiple crossover, multicenter trial to compare SBTs with T-piece versus inspiratory pressure augmentation in weaning outcomes. Mechanically ventilated patients who meet the criteria for readiness to SBT will be included. The patients will use either T-piece or inspiratory pressure augmentation as SBT for weaning according to an ICU-based cluster randomization and crossover sequence.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Crossover sequence 1 | Active Comparator | Cluster-randomization crossover sequence 1: T-piece during odd-numbered months and inspiratory pressure augmentation during even-numbered months. |
|
| Crossover sequence 2 | Experimental | Cluster-randomization crossover sequence 2: T-piece during even-numbered months and inspiratory pressure augmentation during odd-numbered months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Spontaneous breathing trial (SBT) crossover sequence 1 | Diagnostic Test | SBTs with T-piece breathing for one hour during odd-numbered months and SBTs with inspiratory pressure augmentation for one hour during even-numbered months. |
| Measure | Description | Time Frame |
|---|---|---|
| Successful liberation from invasive mechanical ventilation | The primary study endpoint is to compare the effect of SBT with T-piece versus inspiratory pressure augmentation on the proportion of patients with successful liberation from invasive mechanical ventilation in the ICU among patients who have started an SBT. Successful liberation is defined as sustaining iMV free for at least five days after extubation. | ICU discharge, up to 28 days after the initial SBT |
| Measure | Description | Time Frame |
|---|---|---|
| Successful liberation from invasive and noninvasive mechanical ventilation | Proportion of successful liberation from invasive and noninvasive mechanical ventilation in the ICU. | ICU discharge, up to 28 days after the initial SBT |
| Successful liberation from invasive mechanical ventilation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniel Fu-Chang Tsai, MD, PhD | National Taiwan University Hospital | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Taiwan University Hospital | Taipei | Please Select | 10002 | Taiwan | ||
| National Taiwan University Hospital Hsin-Chu Branch |
The individual participant data are available from the corresponding author on reasonable request.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012131 | Respiratory Insufficiency |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015610 | Serum Bactericidal Test |
| ID | Term |
|---|---|
| D008826 | Microbial Sensitivity Tests |
| D008828 | Microbiological Techniques |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
Not provided
Not provided
Cluster-Randomized Crossover Trial
Not provided
Not provided
Not provided
Not provided
| Spontaneous breathing trial (SBT) crossover sequence 2 | Diagnostic Test | SBTs with inspiratory pressure augmentation for one hour during odd-numbered months and SBTs with T-piece breathing for one hour during even-numbered months. |
|
Proportion of successful liberation from invasive mechanical ventilation on day 28 from intubation. |
| 28 days |
| Time to successful liberation from invasive mechanical ventilation | Time to successful liberation from invasive mechanical ventilation using competing-risks analysis. | 28 days |
| Time to successful liberation from invasive and noninvasive mechanical ventilation | Time to successful liberation from invasive and noninvasive mechanical ventilation using competing-risks analysis. | 28 days |
| Intubation free days | The number of days that a patient is alive and free from intubation. | 28 days |
| Adjusted risk ratio of successful liberation from invasive mechanical ventilation | Adjusted risk ratio of successful liberation from invasive mechanical ventilation for T-piece versus inspiratory pressure augmentation group. | ICU discharge, up to 28 days after the initial SBT |
| Initial SBT success | Proportion of initial SBT success among patients who have started an SBT. | During the ICU stay, up to 28 days |
| Extubation failure | Proportion of extubation failure among patients undergoing planned extubation. | Five days from extubation |
| Proportion of planned extubation | Proportion of planned extubation in the ICU | ICU discharge, up to 28 days after the initial SBT |
| Use of noninvasive ventilation after extubation | Proportion of use of noninvasive ventilation (>24 hours) after extubation. | Five days from extubation |
| ICU mortality | Proportion of death in the ICU. | ICU discharge, up to 28 days after the initial SBT |
| 28-day mortality | Probability of death in 28 days using kaplan-meier estimator. | 28 days |
| Hsinchu |
| Taiwan |
| National Taiwan University Hospital Yunlin Branch | Yunlin | 63247 | Taiwan |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
| D004353 | Drug Evaluation, Preclinical |
| D005069 | Evaluation Studies as Topic |